Opsens Inc T.OPS

Healthcare Medical Devices

OpSens Inc. is a medical device cardiology-focused company. The Company offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. The Company’s segments include Medical and Industrial. The Medical segment focuses on physiological measurements, such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR) in the coronary artery disease market and also supplies a range of miniature optical sensors to measure pressure and temperature to be used in a range of applications that can be integrated into other medical devices. The Industrial segment develops, manufactures and installs fiber optic sensing solutions for critical and demanding industrial applications. Its flagship product, the OptoWire, is a second-generation fiber optic pressure guidewire designed to provide the lowest drift in the industry and lesions access. It is approved for sale in the United States, European Union, Japan and Canada.

TSX:OPS - Post by User

Opsens Inc > It will trade to the diluted price of $1.90 and below

<< Previous

Bullboard Posts

Next >>

Comment by retiredcfon Dec 02, 2022 9:55am

119 Views

Post# 35146084

RE:It will trade to the diluted price of $1.90 and below

My bet is that because of its potential, CTS will remain above $1.90 notwithstanding the lousy market. An economic slowdown in China, war in the Ukraine, etc. should have no bearing on the future for an innovative medical procedure. But if I'm wrong and it does drop below $1.90, long term investors should be buying with both hands. GLTA

<< Previous

Bullboard Posts

Next >>

Fobi AI responds to cease trade order, filing delay “disappointing”